But do these patches actually contain GLP-1s, and do they actually work
For example, Kaiser Permanente Northwest Region covers Wegovy as a prescription drug benefit if patients meet the following criteria: Have been diagnosed with chronic weight management Are 18 years or older Have documented their current weight and body mass index (BMI) Are actively following a diet and exercise program Have a BMI of 30 or higher or have a BMI of 27 or higher, plus hypertension, diabetes, or hyperlipidemia Failed a three-month trial or has an allergy, intolerance, or contraindication to phentermine, diethylpropion, Qsymia, and Contrave Failed a three-month trial of Ozempic Medicare doesnt cover medications strictly for weight loss, so Kaiser Medicare Part D plans typically wont cover Wegovy for weight loss alone
M6: \(\beta\)=0.43, 95% CI 0.29, 0.58
Drug availability, indications, and insurance coverage can change over time
Eli Lilly has announced that Phase 3 clinical trials (the TRIUMPH programme ) are underway, investigating retatrutide across a broader population and over longer timeframes
